Results
Latest quarterly results
Companies that reported quarterly results recently, newest first. Each row compares the reported quarter with the same quarter a year earlier. Figures in USD; revenue and net income in millions.
SectorAll 3892Healthcare 878Financial Services 629Technology 560Industrials 517Consumer Cyclical 330Basic Materials 232Energy 196Communication Services 168Real Estate 161Consumer Defensive 134Utilities 87
| Company | Sector | Reported | Quarter | Revenue | Rev. YoY | Net income | NI YoY | EPS | EPS YoY | Op. margin | Margin chg. | Market cap |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BTMDBiote Corp. | Healthcare | Nov 4 | Sep '26 | $43.0M | −10.4% | $0.0M | −100.0% | $0.01 | −95.5% | 5.7% | −11.5 pp | $44M |
| MCRBSeres Therapeutics, Inc. | Healthcare | Nov 4 | Sep '26pending | $0.6M† | n/m | — | — | — | — | — | — | $14M |
| ARAYAccuray Incorporated | Healthcare | Nov 4 | Sep '26pending | $86.5M† | −8.0% | — | — | — | — | — | — | $7M |
| APREAprea Therapeutics, Inc. | Healthcare | Nov 4 | Sep '26pending | — | — | — | — | — | — | — | — | $6M |
| AMGNAmgen Inc. | Healthcare | Nov 3 | Sep '26 | $10.37B | +8.5% | $3.86B | +20.1% | $7.08 | +19.4% | 35.8% | +9.4 pp | $247.7B |
| PFEPfizer, Inc. | Healthcare | Nov 3 | Sep '26 | $16.58B | −0.4% | $3.24B | −8.4% | $0.56 | −9.7% | 22.1% | −11.1 pp | $162.2B |
| TEVATeva Pharmaceutical Industries Limited | Healthcare | Nov 3 | Sep '26 | $4.39B | −1.9% | $233M | −46.2% | $0.20 | −45.9% | 16.3% | −3.4 pp | $49.7B |
| WATWaters Corporation | Healthcare | Nov 3 | Sep '26 | $1.77B | +120.9% | $81.0M | −45.6% | $0.82 | −67.2% | 7.2% | −16.8 pp | $44.2B |
| PHGKoninklijke Philips N.V. NY Registry Shares | Healthcare | Nov 3 | Sep '26 | $4.93B | +1.5% | — | −85.3% | $0.46 | −84.2% | 10.8% | +3.1 pp | $28.9B |
| RVTYRevvity, Inc. | Healthcare | Nov 3 | Sep '26 | $729M | +4.3% | $62.0M | +31.9% | $0.56 | +40.0% | 13.1% | +1.3 pp | $16.5B |
| MDGLMadrigal Pharmaceuticals, Inc. | Healthcare | Nov 3 | Sep '26 | $431M | +50.2% | $55.0M | n/m | $1.83 | n/m | 13.0% | +52.7 pp | $9.8B |
| HSICHenry Schein, Inc. | Healthcare | Nov 3 | Sep '26 | $3.47B | +4.0% | $119M | +17.8% | $1.06 | +26.2% | 6.2% | +0.0 pp | $9.2B |
| SYRESpyre Therapeutics, Inc. | Healthcare | Nov 3 | Sep '26 | $0.0M | n/m | −$96.0M | n/m | −$0.94 | n/m | — | — | $8.9B |
| RYTMRhythm Pharmaceuticals, Inc. | Healthcare | Nov 3 | Sep '26 | $92.0M | +80.4% | −$41.0M | n/m | −$0.61 | n/m | -42.6% | +60.0 pp | $8.1B |
| CORTCorcept Therapeutics Incorporated | Healthcare | Nov 3 | Sep '26 | $340M | +63.5% | $127M | +535.0% | $1.01 | +531.3% | 33.7% | +28.8 pp | $7.7B |
| ALKSAlkermes plc | Healthcare | Nov 3 | Sep '26 | $480M | +21.8% | $16.0M | −80.7% | $0.09 | −81.6% | 7.5% | −15.1 pp | $7.6B |
| AMRXAmneal Pharmaceuticals, Inc. | Healthcare | Nov 3 | Sep '26 | $863M | +9.9% | −$7.0M | −450.0% | −$0.06 | −700.0% | 11.1% | +11.1 pp | $7.4B |
| MIRMMirum Pharmaceuticals, Inc. | Healthcare | Nov 3 | Sep '26 | $186M | +39.8% | −$41.0M | −1,467% | −$0.62 | −1,340% | -32.2% | −34.1 pp | $6.0B |
| SHCSotera Health Company | Healthcare | Nov 3 | Sep '26 | $325M | +4.5% | $58.0M | +20.8% | $0.20 | +17.6% | 35.0% | −0.7 pp | $4.6B |
| STVNStevanato Group S.p.A. | Healthcare | Nov 3 | Sep '26 | $369M | +6.9% | — | +16.7% | $0.18 | +23.1% | 17.6% | +0.2 pp | $4.2B |
| TARSTarsus Pharmaceuticals, Inc. | Healthcare | Nov 3 | Sep '26 | $195M | +63.9% | −$668M | n/m | −$14.40 | n/m | -340.3% | −328.1 pp | $3.9B |
| DNLIDenali Therapeutics Inc. | Healthcare | Nov 3 | Sep '26 | $18.0M | n/m | $70.0M | n/m | $0.37 | n/m | -713.0% | — | $2.9B |
| ATRCAtriCure, Inc. | Healthcare | Nov 3 | Sep '26 | $154M | +14.9% | $4.0M | n/m | $0.08 | n/m | 2.8% | +2.7 pp | $2.8B |
| IDYAIDEAYA Biosciences, Inc. | Healthcare | Nov 3 | Sep '26 | $10.0M | −95.2% | −$126M | −205.9% | −$1.22 | −191.7% | — | — | $2.6B |
| UFPTUFP Technologies, Inc. | Healthcare | Nov 3 | Sep '26 | $172M | +11.0% | $21.0M | +31.3% | $2.64 | +25.1% | 16.0% | +0.9 pp | $2.3B |
| ADUSAddus HomeCare Corporation | Healthcare | Nov 3 | Sep '26 | $388M | +7.2% | $29.0M | +26.1% | $1.54 | +24.2% | 10.3% | +1.2 pp | $2.3B |
| BEAMBeam Therapeutics Inc. | Healthcare | Nov 3 | Sep '26 | $0.0M | n/m | −$134M | n/m | −$1.28 | n/m | — | — | $2.1B |
| ALMRAlamar Biosciences, Inc. | Healthcare | Nov 3 | Sep '26 | $34.0M | — | −$13.0M | — | −$0.19 | — | -45.1% | — | $2.1B |
| TRAXFirst Tracks Biotherapeutics, Inc. | Healthcare | Nov 3 | Sep '26 | $0.0M | — | −$31.0M | — | −$0.88 | — | — | — | $1.8B |
| RAREUltragenyx Pharmaceutical Inc. | Healthcare | Nov 3 | Sep '26 | $173M | +8.1% | −$118M | n/m | −$1.16 | n/m | -63.6% | +43.3 pp | $1.7B |
| INNVInnovAge Holding Corp. | Healthcare | Nov 3 | Sep '26 | $265M | +12.3% | $20.0M | +150.0% | $0.14 | +133.3% | 7.6% | +4.1 pp | $1.3B |
| AHCOAdaptHealth Corp. | Healthcare | Nov 3 | Sep '26 | $746M | +23.7% | −$154M | −716.0% | −$1.13 | −806.2% | -20.9% | −32.0 pp | $1.0B |
| CBLLCeriBell, Inc. | Healthcare | Nov 3 | Sep '26 | $29.0M | +26.1% | −$21.0M | n/m | −$0.55 | n/m | -70.0% | −5.2 pp | $1.0B |
| ARDXArdelyx, Inc. | Healthcare | Nov 3 | Sep '26 | $128M | +16.4% | −$1.0M | n/m | $0.00 | n/m | 3.1% | −1.1 pp | $799M |
| QDELQuidelOrtho Corporation | Healthcare | Nov 3 | Sep '26 | $619M | −11.6% | −$54.0M | n/m | −$0.78 | n/m | -1.2% | +99.5 pp | $677M |
| SOPHSOPHiA GENETICS SA | Healthcare | Nov 3 | Sep '26 | $24.0M | +26.3% | −$20.0M | n/m | −$0.24 | n/m | -73.5% | +18.3 pp | $634M |
| ZVRAZevra Therapeutics, Inc. | Healthcare | Nov 3 | Sep '26pending | $37.8M† | +45.2% | — | — | — | — | — | — | $559M |
| AQSTAquestive Therapeutics, Inc. | Healthcare | Nov 3 | Sep '26 | $8.0M | −38.5% | −$16.0M | n/m | −$0.13 | n/m | -191.5% | −101.8 pp | $465M |
| OCSOculis Holding AG | Healthcare | Nov 3 | Sep '26pending | $0.0M† | n/m | — | — | — | — | — | — | $464M |
| ARVNArvinas, Inc. | Healthcare | Nov 3 | Sep '26pending | $0.5M† | −98.8% | — | — | — | — | — | — | $447M |
| CTNMContineum Therapeutics, Inc. | Healthcare | Nov 3 | Sep '26 | $0.0M | n/m | −$19.0M | n/m | −$0.49 | n/m | — | — | $338M |
| FTHFaeth Therapeutics, Inc. | Healthcare | Nov 3 | Sep '26 | $0.0M | n/m | −$20.0M | n/m | −$0.79 | n/m | — | — | $233M |
| LABStandard BioTools Inc. | Healthcare | Nov 3 | Sep '26 | $19.0M | −5.0% | $13.0M | n/m | $0.03 | n/m | -102.0% | +18.0 pp | $213M |
| RXSTRxSight, Inc. | Healthcare | Nov 3 | Sep '26pending | $24.6M† | −18.0% | — | — | — | — | — | — | $203M |
| DTILPrecision BioSciences, Inc. | Healthcare | Nov 3 | Sep '26 | $0.0M | n/m | −$8.0M | n/m | −$0.28 | n/m | — | — | $197M |
| AMWLAmerican Well Corporation | Healthcare | Nov 3 | Sep '26pending | $49.0M† | −12.5% | — | — | — | — | — | — | $174M |
| IFRXInflaRx N.V. | Healthcare | Nov 3 | Sep '26 | — | n/m | — | n/m | −$0.02 | n/m | — | — | $169M |
| INMInMed Pharmaceuticals Inc. | Healthcare | Nov 3 | Sep '26 | $0.0M | n/m | −$2.33B | n/m | −$0.43 | n/m | — | — | $9M |
| VRTXVertex Pharmaceuticals Incorporated | Healthcare | Nov 2 | Sep '26 | $3.44B | +11.9% | $654M | −39.6% | $2.56 | −39.0% | 20.7% | −17.8 pp | $135.4B |
| IDXXIDEXX Laboratories, Inc. | Healthcare | Nov 2 | Sep '26 | $1.21B | +9.9% | $317M | +15.3% | $4.01 | +17.9% | 33.1% | +1.0 pp | $54.4B |
- Report dates come from the earnings calendar (dates loaded Oct 4 to Dec 9); figures come from the quarterly statements stored for each company. Click a ticker for its full statements.
- YoY compares the reported quarter with the same quarter a year earlier. n/m (not meaningful) means the year-earlier figure was zero or negative, so a percentage change would not describe it. Margin change is in percentage points.
- pending: the company has reported, but that quarter is not in our statements yet. Revenue marked † is the announced figure from the earnings calendar; the other columns fill in once the statements update.
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.